Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference

Rhea-AI Summary

Nautilus Biotechnology (NASDAQ: NAUT) will participate in the TD Cowen 46th Annual Health Care Conference. Management is scheduled for a fireside chat on March 2, 2026 at 10:30 a.m. ET. A live and archived webcast will be available on the company Investors website at www.nautilus.bio.

News Market Reaction – NAUT

+2.05%

15 alerts

+2.05% News Effect

+14.5% Peak in 5 hr 56 min

+$7M Valuation Impact

$370M Market Cap

0.8x Rel. Volume

On the day this news was published, NAUT gained 2.05%, reflecting a moderate positive market reaction. Argus tracked a peak move of +14.5% during that session. Our momentum scanner triggered 15 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $7M to the company's valuation, bringing the market cap to $370M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Conference edition: 46th annual Presentation date: March 2, 2026 Presentation time: 10:30 a.m. Eastern Time

3 metrics

Conference edition 46th annual TD Cowen Health Care Conference

Presentation date March 2, 2026 Fireside chat schedule

Presentation time 10:30 a.m. Eastern Time TD Cowen fireside chat

Market Reality Check

Price: $2.82 Vol: Volume 40,598 is at 0.21x...

low vol

$2.82 Last Close

Volume Volume 40,598 is at 0.21x the 20-day average of 194,003, indicating limited trading interest pre-conference. low

Technical Shares at $2.68 trade 6.06% below the 52-week high of $2.85 and remain above the 200-day MA at $1.26.

Peers on Argus

NAUT is up 2.05% with light volume while peers are mixed: CSBR down 1.02%, IPA u...

NAUT is up 2.05% with light volume while peers are mixed: CSBR down 1.02%, IPA up 3.5%, QNCX up 11.11%, EXOZ up 2.56%, SEER flat. Moves do not point to a unified sector trend.

Common Catalyst One peer, SEER, also issued research-focused news, suggesting ongoing interest in proteomics and disease research presentations rather than a broad sector catalyst.

Historical Context

5 past events · Latest: Feb 05 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 05	Earnings date notice	Neutral	-2.9%	Announced timing of Q4 and full-year 2025 results and webcast details.
Jan 28	Research partnership	Positive	-7.6%	MJFF-supported collaboration on Parkinson’s single-molecule proteomics assay.
Jan 08	Platform early access	Positive	+0.0%	Launched early access program focused on tau proteoforms assay for researchers.
Nov 03	Field unit validation	Positive	+39.1%	Reported first external field evaluation unit with reproducible multi-site data.
Oct 28	Q3 2025 earnings	Positive	+5.9%	Lower operating expenses, narrower loss, and strong cash balance disclosure.

Pattern Detected

Operational and collaboration updates have sometimes seen muted or negative reactions, while milestone validation events, like the Buck Institute field unit, drew a strong positive move.

Recent Company History

Over the past several months, Nautilus highlighted progress toward commercialization and scientific validation. A Q3 2025 earnings release on Oct 28, 2025 with reduced operating expenses and a $168.5M cash balance saw a 5.93% gain. Installation of the first field evaluation unit at the Buck Institute on Nov 3, 2025 triggered a 39.1% jump. In contrast, a $1.6M Parkinson’s collaboration grant on Jan 28, 2026 and the early access program launch on Jan 8, 2026 saw negative or flat reactions, showing inconsistent responses to positive operational news compared with validation milestones.

Market Pulse Summary

This announcement highlights Nautilus’ upcoming fireside chat at a major health care conference on M...

Analysis

This announcement highlights Nautilus’ upcoming fireside chat at a major health care conference on March 2, 2026, which can increase visibility for its single-molecule proteomics platform. In recent months, the company reported progress toward early access and a broader commercial launch in 2026, alongside collaborations in neurodegenerative and Parkinson’s research. Investors may track how management discusses timelines, cash runway from prior filings, and adoption of early access programs during the conference presentation.

Key Terms

webcast

1 terms

webcast technical

"Interested parties may access a live and archived webcast of the presentation"

A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

AI-generated analysis. Not financial advice.

SEATTLE, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the TD Cowen 46^th Annual Health Care Conference.

Nautilus’ management is scheduled to participate in a fireside chat on Monday, March 2, 2026, at 10:30 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.nautilus.bio.

About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.

Media Contact
press@nautilus.bio

Investor Contact
investorrelations@nautilus.bio

FAQ

When will Nautilus Biotechnology (NAUT) present at the TD Cowen 46th Annual Health Care Conference?

Nautilus management will present in a fireside chat on March 2, 2026 at 10:30 a.m. ET. According to the company, the session is part of the TD Cowen 46th Annual Health Care Conference and is open via webcast for investors and interested parties.

How can investors watch Nautilus Biotechnology's (NAUT) presentation at the TD Cowen conference?

Investors can access a live and archived webcast on the company's Investors website at www.nautilus.bio. According to the company, the webcast will be available live on March 2, 2026 and archived afterwards for on-demand viewing.

What is the scheduled format for Nautilus Biotechnology's (NAUT) participation at the TD Cowen event?

Nautilus is scheduled for a fireside chat format during the conference on March 2, 2026 at 10:30 a.m. ET. According to the company, management will discuss company developments and answer questions in that moderated format.

Will Nautilus Biotechnology (NAUT) provide an archived recording of its TD Cowen presentation?

Yes, an archived webcast will be available on the company's Investors website after the live session. According to the company, the archived recording will allow investors to review the March 2, 2026 fireside chat on demand.

Why is Nautilus Biotechnology (NAUT) participating in the TD Cowen 46th Annual Health Care Conference?

The company is participating to present management perspectives and company updates to investors and analysts. According to the company, the March 2, 2026 fireside chat provides a platform to communicate its single-molecule protein analysis progress and strategic priorities.